Metabolic and structural rearrangement during dark-induced autophagy in soybean (Glycine max L.) nodules: An electron microscopy and P-31 and C-13 nuclear magnetic resonance study

The effects of dark-induced stress on the evolution of the soluble metabolites present in senescent soybean (Glycine max L.) nodules were analysed in vitro using C-13- and P-31-NMR spectroscopy. Sucrose and trehalose were the predominant soluble storage carbons. During dark-induced stress, a decline in sugars and some key glycolytic metabolites was observed. Whereas 84% of the sucrose disappeared, only one-half of the trehalose was utilised. This decline coincides with the depletion of Gln, Asn, Ala and with an accumulation of ureides, which reflect a huge reduction of the N-2 fixation. Concomitantly, phosphodiesters and compounds like P-choline, a good marker of membrane phospholipids hydrolysis and cell autophagy, accumulated in the nodules. An autophagic process was confirmed by the decrease in cell fatty acid content. In addition, a slight increase in unsaturated fatty acids (oleic and linoleic acids) was observed, probably as a response to peroxidation reactions. Electron microscopy analysis revealed that, despite membranes dismantling, most of the bacteroids seem to be structurally intact. Taken together, our results show that the carbohydrate starvation induced in soybean by dark stress triggers a profound metabolic and structural rearrangement in the infected cells of soybean nodule which is representative of symbiotic cessation.

Fusion weld metal solidification:Continuum from weld interface to centerline

We present a brief résumé of the history of solidification research and key factors affecting the solidification of fusion welds. There is a general agreement of the basic solidification theory, albeit differing - even confusing - nomenclatures do exist, and Cases 2 and 3 (the Chalmers' basic boundary conditions for solidification, categorized by Savage as Cases) are variably emphasized. Model Frame, a tool helping to model the continuum of fusion weld solidification from start to end, is proposed. It incorporates the general solidification models, of which the pertinent ones are selected for the actual modeling. The basic models are the main solidification Cases 1…4. These discrete Cases are joined with Sub-Cases: models of Pfann, Flemings and others, bringing needed Sub-Case variables into the model. Model Frame depicts a grain growing from the weld interface to its centerline. Besides modeling, the Model Frame supports education and academic debate. The new mathematical modeling techniques will extend its use into multi-dimensional modeling, introducing new variables and increasing the modeling accuracy. We propose a model: melting/solidification-model (M/S-model) - predicting the solute profile at the start of the solidification of a fusion weld. This Case 3-based Sub-Case takes into account the melting stage, the solute back-diffusion in the solid, and the growth rate acceleration typical to fusion welds. We propose - based on works of Rutter & Chalmers, David & Vitek and our experimental results on copper - that NEGS-EGS-transition is not associated only with cellular-dendritic-transition. Solidification is studied experimentally on pure and doped copper with welding speed range from 0 to 200 cm/min, with one test at 3000 cm/min. Found were only planar and cellular structures, no dendrites - columnar or equiaxed. Cell sub structures: rows of cubic elements we call "cubelettes", "cell-bands" and "micro-cells", as well as an anomalous crack morphology "crack-eye", were detected, as well as microscopic hot crack nucleus we call "grain-lag cracks", caused by a grain slightly lagging behind its neighbors in arrival to the weld centerline. Varestraint test and R-test revealed a change of crack morphologies from centerline cracks to grainand cell boundary cracks with an increasing welding speed. High speed made the cracks invisible to bare eye and hardly detectable with light microscope, while electron microscope often revealed networks of fine micro-cracks.

Versatility of field theory motivated nuclear effective Lagrangian approach

We analyze the results for infinite nuclear and neutron matter using the standard relativistic mean field model and its recent effective field theory motivated generalization. For the first time, we show quantitatively that the inclusion in the effective theory of vector meson self-interactions and scalar-vector cross-interactions explains naturally the recent experimental observations of the softness of the nuclear equation of state, without losing the advantages of the standard relativistic model for finite nuclei.

Intercomparação e calibração de medidores de atividade utilizados em serviços de medicina nuclear

OBJETIVO: O objetivo deste trabalho foi estabelecer um padrão de trabalho para intercomparação e calibração de medidores de atividade (calibradores de dose) utilizados na maioria dos serviços de medicina nuclear, para determinação da atividade dos radionuclídeos administrados aos pacientes nos exames específicos ou nos procedimentos terapêuticos. MATERIAIS E MÉTODOS: Foi utilizado um calibrador de dose comercial, um conjunto de fontes radioativas padrões, além de seringas, frascos e ampolas contendo soluções de radionuclídeos utilizados em medicina nuclear. RESULTADOS: O calibrador de dose comercial foi calibrado com soluções de radionuclídeos utilizados em medicina nuclear. Os testes simples do instrumento, tais como o teste de linearidade e da variação da resposta com o volume da fonte a uma concentração de atividade constante, foram descritos e realizados. CONCLUSÃO: O instrumento estudado pode agora ser utilizado como sistema de referência para intercomparação e calibração de outros instrumentos medidores de atividade, como um método de controle da qualidade de calibradores de dose utilizados em serviços de medicina nuclear.

Proposta de método de inspeção de radioproteção aplicada em instalações de medicina nuclear

O objetivo principal deste trabalho é implantar um método de inspeção imparcial e eficiente, visando à utilização segura e correta das radiações ionizantes no campo da medicina nuclear. Este método de inspeção aqui proposto foi aplicado em 113 serviços de medicina nuclear do país, obedecendo a uma freqüência de análise bienal (1996, 1998, 2000 e 2002). Foram estabelecidos 82 itens de radioproteção com pesos para cada item, baseados nos fatores de risco, de acordo com as normas da Comissão Nacional de Energia Nuclear (CNEN) e as recomendações da Agência Internacional de Energia Atômica. Na análise do serviço, cada item de não conformidade com as normas da CNEN gerou uma irregularidade de radioproteção, com seu peso associado. O somatório dos pesos deu a cada serviço uma pontuação final que o classificou dentro de três faixas de valores que determinaram uma tomada de decisão por parte do órgão regulador e fiscalizador: funcionamento sem restrição - menor que 100 pontos; funcionamento com restrição - igual ou maior que 100 e menor que 300 pontos; funcionamento suspenso - igual ou maior que 300 pontos. Para o caso de irregularidades reincidentes, criou-se um fator multiplicativo para a pontuação. A reincidência em qualquer item de radioproteção (irregularidade) teve seu peso multiplicado por 2n, onde n era o número de vezes em que o item encontrava-se irregular. O estabelecimento prévio de itens de radioproteção, com atribuição de pesos para cada item, procurou minimizar os valores subjetivos e pessoais presentes no julgamento e na avaliação técnica das instituições inspecionadas.

Neutron skin of 208Pb, nuclear symmetry energy, and the parity radius experiment

A precise determination of the neutron skin thickness of a heavy nucleus sets a basic constraint on the nuclear symmetry energy (the neutron skin thickness is the difference of the neutron and proton rms radii of the nucleus). The parity radius experiment (PREX) may achieve it by electroweak parity-violating electron scattering (PVES) on 208Pb. We investigate PVES in nuclear mean field approach to allow the accurate extraction of the neutron skin thickness of 208Pb from the parity-violating asymmetry probed in the experiment. We demonstrate a high linear correlation between the parity-violating asymmetry and the neutron skin thickness in successful mean field forces as the best means to constrain the neutron skin of 208Pb from PREX, without assumptions on the neutron density shape. Continuation of the experiment with higher precision in the parity-violating asymmetry is motivated since the present method can support it to constrain the density slope of the nuclear symmetry energy to new accuracy.

MRI/TRUS fusion software-based targeted biopsy: the new standard of care?

The advent of multiparametric MRI has made it possible to change the way in which prostate biopsy is done, allowing to direct biopsies to suspicious lesions rather than randomly. The subject of this review relates to a computer-assisted strategy, the MRI/US fusion software-based targeted biopsy, and to its performance compared to the other sampling methods. Different devices with different methods to register MR images to live TRUS are currently in use to allow software-based targeted biopsy. Main clinical indications of MRI/US fusion software-based targeted biopsy are re-biopsy in men with persistent suspicious of prostate cancer after first negative standard biopsy and the follow-up of patients under active surveillance. Some studies have compared MRI/US fusion software-based targeted versus standard biopsy. In men at risk with MRI-suspicious lesion, targeted biopsy consistently detects more men with clinically significant disease as compared to standard biopsy; some studies have also shown decreased detection of insignificant disease. Only two studies directly compared MRI/US fusion software-based targeted biopsy with MRI/US fusion visual targeted biopsy, and the diagnostic ability seems to be in favor of the software approach. To date, no study comparing software-based targeted biopsy against in-bore MRI biopsy is available. The new software-based targeted approach seems to have the characteristics to be added in the standard pathway for achieving accurate risk stratification. Once reproducibility and cost-effectiveness will be verified, the actual issue will be to determine whether MRI/TRUS fusion software-based targeted biopsy represents anadd-on test or a replacement to standard TRUS biopsy.

Nuclear Factor I-C acts as a regulator of hepatocyte proliferation at the onset of liver regeneration.

BACKGROUND & AIMS: Knockout studies of the murine Nuclear Factor I-C (NFI-C) transcription factor revealed abnormal skin wound healing and growth of its appendages, suggesting a role in controlling cell proliferation in adult regenerative processes. Liver regeneration following partial hepatectomy (PH) is a well-established regenerative model whereby changes elicited in hepatocytes lead to their rapid and phased proliferation. Although NFI-C is highly expressed in the liver, no hepatic function was yet established for this transcription factor. This study aimed to determine whether NFI-C may play a role in hepatocyte proliferation and liver regeneration. METHODS: Liver regeneration and cell proliferation pathways following two-thirds PH were investigated in NFI-C knockout (ko) and wild-type (wt) mice. RESULTS: We show that the absence of NFI-C impaired hepatocyte proliferation because of plasminogen activator I (PAI-1) overexpression and the subsequent suppression of urokinase plasminogen activator (uPA) activity and hepatocyte growth factor (HGF) signalling, a potent hepatocyte mitogen. This indicated that NFI-C first acts to promote hepatocyte proliferation at the onset of liver regeneration in wt mice. The subsequent transient down regulation of NFI-C, as can be explained by a self-regulatory feedback loop with transforming growth factor beta 1 (TGF-ß1), may limit the number of hepatocytes entering the first wave of cell division and/or prevent late initiations of mitosis. CONCLUSION: NFI-C acts as a regulator of the phased hepatocyte proliferation during liver regeneration.

Análise dosimétrica de acompanhantes de pacientes de medicina nuclear internados em quarto terapêutico

OBJETIVO: Este trabalho avaliou doses recebidas por acompanhantes que compartilharam o mesmo quarto terapêutico com pacientes tratados com câncer de tireóide ingerindo iodo-131 (131I) e comparou os resultados obtidos aos limites determinados pelas normas brasileiras de radioproteção. MATERIAIS E MÉTODOS: Avaliaram-se seis grupos de pessoas. Cada grupo foi formado por um acompanhante e um paciente, que compartilharam o mesmo quarto terapêutico. Realizaram-se, também, 23 outros experimentos, sendo que nestes um simulador foi usado em substituição à segunda pessoa no quarto terapêutico. As atividades de 131I administradas aos pacientes foram de 3.700 MBq ou 5.550 MBq. Dosímetros termoluminescentes na forma de pó, fluoreto de lítio dopado com magnésio, titânio e sódio foram usados para a avaliação das doses. RESULTADOS: Os resultados mostraram que uma pessoa que compartilha o mesmo quarto terapêutico, durante dois dias, com um paciente tratado com 3.700 MBq ou 5.550 MBq de 131I, seguindo as orientações de radioproteção fornecidas pela equipe médica, é exposta a uma dose média de (0,51 ± 0,02) mSv, para um nível de confiança de 99%. CONCLUSÃO: De acordo com as normas brasileiras, do ponto de vista da radioproteção, não há impedimento acompanhar um paciente de medicina nuclear durante esse tratamento.

Levantamento do controle de qualidade de calibradores de dose de radiofármacos em serviços de medicina nuclear na cidade de São Paulo

OBJETIVO: Realizar levantamento sobre quais testes de controle de qualidade são realizados nos calibradores de dose dos serviços de medicina nuclear da cidade de São Paulo, SP. Estudar a exatidão das medições de atividade de sete calibradores de dose no Laboratório de Calibração de Instrumentos do Instituto de Pesquisas Energéticas e Nucleares, usando fontes de radionuclídeos importantes clinicamente. MATERIAIS E MÉTODOS: O levantamento sobre o controle de qualidade foi realizado a partir de questionários enviados aos serviços. Foram utilizados, no estudo de exatidão dos sete calibradores de dose, fontes de Ga-67, Tc-99m e Tl-201 e um instrumento padrão secundário. RESULTADOS: Os resultados do levantamento sobre os testes de controle de qualidade mostraram algumas impropriedades, por exemplo, a falta da realização diária do teste de reprodutibilidade por todos os serviços. Os resultados do teste de exatidão para os sete calibradores de dose estudados mostraram-se dentro do limite de aceitação da norma nacional (±10%). CONCLUSÃO: A situação com relação ao controle de qualidade de calibradores de dose é insatisfatória, de acordo com o pequeno número de serviços que participaram do levantamento. O estudo da exatidão em sete calibradores de dose não indicou falhas de desempenho e estabeleceu uma calibração desses instrumentos para as fontes utilizadas.

Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group.

PURPOSE: Pediatric rhabdomyosarcoma (RMS) has two common histologic subtypes: embryonal (ERMS) and alveolar (ARMS). PAX-FOXO1 fusion gene status is a more reliable prognostic marker than alveolar histology, whereas fusion gene-negative (FN) ARMS patients are clinically similar to ERMS patients. A five-gene expression signature (MG5) previously identified two diverse risk groups within the fusion gene-negative RMS (FN-RMS) patients, but this has not been independently validated. The goal of this study was to test whether expression of the MG5 metagene, measured using a technical platform that can be applied to routine pathology material, would correlate with outcome in a new cohort of patients with FN-RMS. EXPERIMENTAL DESIGN: Cases were taken from the Children's Oncology Group (COG) D9803 study of children with intermediate-risk RMS, and gene expression profiling for the MG5 genes was performed using the nCounter assay. The MG5 score was correlated with clinical and pathologic characteristics as well as overall and event-free survival. RESULTS: MG5 standardized score showed no significant association with any of the available clinicopathologic variables. The MG5 signature score showed a significant correlation with overall (N = 57; HR, 7.3; 95% CI, 1.9-27.0; P = 0.003) and failure-free survival (N = 57; HR, 6.1; 95% CI, 1.9-19.7; P = 0.002). CONCLUSIONS: This represents the first, validated molecular prognostic signature for children with FN-RMS who otherwise have intermediate-risk disease. The capacity to measure the expression of a small number of genes in routine pathology material and apply a simple mathematical formula to calculate the MG5 metagene score provides a clear path toward better risk stratification in future prospective clinical trials. Clin Cancer Res; 21(20); 4733-9. ©2015 AACR.